Pyrimidines As Plk Inhibitors

Abstract

The present invention encompasses compounds of general formula (1), wherein A, W, X, Y, Z, Ra, Rb, Rc, R1 and R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.


Claims
CPC Classifications

Download Citation


Sign in to the Lens

Feedback